← FDA ENFORCEMENT
D-0540-2025Class II

Mckesson Medical-Surgical Inc. Corporate Office

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
Product type
Drug
Status
Ongoing
Report date
2025-07-30
Distribution
Within the U.S - OH, VA, FL.
Firm state
VA
Product quantity
3 Vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Risk Management & CAPA
Reason for recall

CGMP Deviations; potential temperature excursions due to transit delays

Product description

BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.

Code / lot info

Lot: YK4W, Expiration date: 4/30/2029

Other recalls SPEQ maps to Risk Management & CAPA
2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.2026-07-22Class IAbiomed, Inc.
See all Risk Management & CAPA recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.